Radiotherapy Response Time Did Not Dictate Outcomes for Gastrointestinal Low-Grade B-Cell Lymphoma
Delayed evaluation could decrease unnecessary invasive tests.
All articles by Leah Lawrence
PARP Inhibitors Deemed Too Costly For Across-the-Board Frontline Maintenance in Ovarian Cancer
Broad use of PARP inhibitors to treat advanced-stage ovarian cancer would be associated with high costs compared with their biomarker-directed use.
Experts Establish Surgical Priority Ranking for Head and Neck Cancers
Experts have developed a new tool for surgical prioritization and ranking for patients with head and neck cancer in a scarce-resource settings associated with the COVID-19 pandemic.
European Myeloma Network Provides Vaccine Recommendations for MM
Patients with myeloma should receive 2 doses of the trivalent or quadrivalent vaccine influenza vaccine and vaccinations should continue annually.
Gain in Chromosome 1q Should Be Considered High Risk in Myeloma
The cytogenetic abnormality was linked to inferior overall survival.
Second ASCT Has a Role in Relapsed Multiple Myeloma After First Transplant
Patients who relapsed 3 years or later after first transplant had significantly better progression-free and overall survival compared with those who relapsed earlier.
Uniform Care of Testicular Cancer Overcame Sociodemographic Factors
Guideline-directed care resulted in equivalent outcomes independent of hospital setting.
Biomarker Identified for Anti–PD-1 Treatment in Natural Killer/T-Cell Lymphoma
All responders were found to have the same structural rearrangements.
“Good-Risk” Group of Patients With Myeloma Saw Better Outcomes
A percentage of newly diagnosed patients had disease with lower genomic instability.
Pregnancy After BRCA-Mutated Breast Cancer Deemed Safe
Pregnancy was not linked to differences in survival outcomes.
-
Loading...
-
Loading...
Next post in Breast Cancer
